ClavystBio and A*STAR partner to grow MedTech ventures in Singapore

adicionou um novo artigo Health

2025-06-12 06:54:29 -

ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), Singapore’s lead public sector research and development (R&D) agency, have signed a memorandum of understanding (MoU) to create and grow MedTech ventures in Singapore. ClavystBio said in a statement on Tuesday that this partnership will...

0 Comentários 0 Compartilhamentos 468 Visualizações 0 Anterior